Korea United Pharm, “$4.56 Million Drug Supply Contract to Saudi Arabia”
Korea United Pharm, “$4.56 Million Drug Supply Contract to Saudi Arabia”
  • Cho Eun, Reporter
  • 승인 2023.02.21 14:10
  • 수정 2023.02.21 14:10
  • 댓글 0
이 기사를 공유합니다

Korea United Pharm targets Saudi Arabia, the largest pharmaceutical market in the Middle East.

According to Korea United Pharm on February 20, it has been in discussion of a drug supply contract with Saudi Arabia since 2020 and concluded the contract worth $45.6 million for nine products.

The company explained that the company has been exporting 11 items of anti-cancer drugs through unregistered bidding since 2012 but following the strengthening of SFDA regulations, it has officially signed a supply contract.

In addition, a specialized anti-cancer drug facilities in the Sejong Plant 2 have been approved for GMP from the Saudi FDA and will begin full-scale production and supply this year.

Korea United Pharm has chosen Saudi Arabia, one of the largest pharmaceutical markets in the Middle East and Africa, as a base for its entry into the Middle East and will continue to explore other avenues to enter other major Middle Eastern and African countries as well as the GCC countries.

An official from the company said, "The estimated size of the pharmaceutical market in Saudi Arabia is approximately $10.7 billion, accounting for more than half (55%) of the total market in the GCC countries. With the Saudi government actively supporting and developing the healthcare industry, the market is expected to grow at a CAGR of more than 5.5%."

[WIKI KOREA=Cho Eun, Reporter]

choeun@wikileaks-kr.org


  • 서울특별시 마포구 마포대로 127, 1001호 (공덕동, 풍림빌딩)
  • 대표전화 : 02-702-2677
  • 팩스 : 02-702-1677
  • 청소년보호책임자 : 소정원
  • 법인명 : 위키리크스한국 주식회사
  • 제호 : 위키리크스한국
  • 등록번호 : 서울 아 04701
  • 등록일 : 2013-07-18
  • 발행일 : 2013-07-18
  • 발행인 : 박정규
  • 편집인 : 박찬흥
  • 위키리크스한국은 자체 기사윤리 심의 전문위원제를 운영합니다.
  • 기사윤리 심의 : 박지훈 변호사
  • 위키리크스한국 모든 콘텐츠(영상,기사, 사진)는 저작권법의 보호를 받은바, 무단 전재와 복사, 배포 등을 금합니다.
  • Copyright © 2024 위키리크스한국. All rights reserved.
  • [위키리크스한국 보도원칙] 본 매체는 독자와 취재원 등 뉴스 이용자의 권리 보장을 위해 반론이나 정정보도, 추후보도를 요청할 수 있는 창구를 열어두고 있음을 알립니다.
    고충처리 : 02-702-2677 | 메일 : laputa813@wikileaks-kr.org
ND소프트